AliveCor, the global leader in AI-powered cardiology, today announced the activation of its services and solutions, designed specifically for the U.S. veterans, on the Veterans Affairs (VA) Federal ...

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first ...

Himplant, a leader in cosmetic penile enhancement, is pleased to highlight the publication of a comprehensive study titled ...

Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients with Alzheimer’s disease.

De minimis shipments, valued at $800 or less, are exempt from the rigorous oversight that applies to regular imports.

BEVERLY, Mass., Nov. 4, 2024 /PRNewswire/ -- Award-winning medical technology innovator, Quanta Dialysis Technologies®, has confirmed the US Food and Drug Administration (FDA) has given 510(k) ...

CytoDyn (CYDY) announced that it has received clearance from the FDA to commence its Phase II oncology trial. The study will evaluate the ...

Qiagen (QGEN) announced that the FDA has cleared the QIAstat-Dx Meningitis/Encephalitis Panel for clinical use. This marks the fourth ...

FDA regulations categorize medical devices into three classes, with varying levels of control to manage risks and ensure the safety of medical technologies.

Alimetry has raised an oversubscribed US $18m A2 financing round to commercialize its wearable gut health monitoring device, ...